Moshe Sarfaty
Chief Executive Officer at LS Biopath, Inc.
Profile
Moshe Sarfaty is the founder of Krypton Venture Capital Ltd.
which was founded in 2013.
He held the title of Co-owner from 2013 to 2020.
He is currently the President, Chief Executive Officer & Director at LS Biopath, Inc. and the Managing Partner at Aristagora VC Israel Management Ltd.
since 2020.
Mr. Sarfaty received his undergraduate degree from Yale University in 2008.
Moshe Sarfaty active positions
| Companies | Position | Start |
|---|---|---|
LS Biopath, Inc.
 LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Chief Executive Officer | 2008-12-31 |
| Aristagora VC Israel Management Ltd. | Private Equity Investor | 2020-06-30 |
Former positions of Moshe Sarfaty
| Companies | Position | End |
|---|---|---|
Krypton Venture Capital Ltd.
 Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Founder | 2020-07-01 |
Training of Moshe Sarfaty
| Yale University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Finance |
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Health Technology |
| Aristagora VC Israel Management Ltd. | Finance |
- Stock Market
- Insiders
- Moshe Sarfaty
